Please login to the form below

Not currently logged in
Email:
Password:

Forendo Pharma

This page shows the latest Forendo Pharma news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 335. Forendo Pharma/Apricus Biosciences. Licence [A]. Fispemifene a selective oestrogen modulator in P2 for secondary hypogonadism.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    He becomes a non-executive director. Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors. ... Risto Lammintausta, chief executive officer of Forendo Pharma, said: “We are delighted to welcome David with his

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics